Entera Bio Ltd.

NASDAQ: ENTX · Real-Time Price · USD
1.99
0.02 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.00
0.50%
After-hours: Aug 15, 2025, 07:57 PM EDT

Entera Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
8.66M 11.02M 12.31M 24.89M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
86K 6K 96K 46K
Receivables
126K n/a 246K 183K
Inventory
n/a n/a -294K n/a
Other Current Assets
186K 238K 294K 254K
Total Current Assets
8.97M 11.26M 12.85M 25.33M
Property-Plant & Equipment
332K 488K 139K 395K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
418K 508K 278K 658K
Total Assets
9.39M 11.77M 13.13M 25.99M
Account Payables
132K 83K 17K 166K
Deferred Revenue
n/a n/a 43K 15K
Short-Term Debt
170K n/a 91K 179K
Other Current Liabilities
874K 500K 842K 2.03M
Total Current Liabilities
1.18M 1.09M 1.34M 3.16M
Long-Term Debt
n/a n/a n/a 123K
Other Long-Term Liabilities
32K 32K 32K 15K
Total Long-Term Liabilities
134K 288K 32K 261K
Total Liabilities
1.31M 1.38M 1.37M 3.42M
Total Debt
272K 390K 91K 302K
Common Stock
1K 1K n/a n/a
Retained Earnings
-113.93M -104.39M -95.5M -82.43M
Comprehensive Income
41K 41K 41K 41K
Shareholders Equity
8.08M 10.39M 11.75M 22.57M
Total Investments
n/a n/a n/a n/a